The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gastroparesis Drugs Market Research Report 2025
Synopsis
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
The global Gastroparesis Drugs market was valued at US$ 5659 million in 2023 and is anticipated to reach US$ 7625.2 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Drugs.
Report Scope
The Gastroparesis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastroparesis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroparesis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Segment by Type
Prokinetic Agents
Antiemetic Agents
Others
Segment by Application
Diabetic Gastroparesis
Idiopathic Gastroparesis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastroparesis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastroparesis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
The global Gastroparesis Drugs market was valued at US$ 5659 million in 2023 and is anticipated to reach US$ 7625.2 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Drugs.
Report Scope
The Gastroparesis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastroparesis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroparesis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Segment by Type
Prokinetic Agents
Antiemetic Agents
Others
Segment by Application
Diabetic Gastroparesis
Idiopathic Gastroparesis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastroparesis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastroparesis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gastroparesis Drugs Market Overview
1.1 Product Overview and Scope of Gastroparesis Drugs
1.2 Gastroparesis Drugs Segment by Type
1.2.1 Global Gastroparesis Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Gastroparesis Drugs Segment by Application
1.3.1 Global Gastroparesis Drugs Market Value by Application: (2024-2030)
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Global Gastroparesis Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastroparesis Drugs Revenue 2019-2030
1.4.2 Global Gastroparesis Drugs Sales 2019-2030
1.4.3 Global Gastroparesis Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gastroparesis Drugs Market Competition by Manufacturers
2.1 Global Gastroparesis Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gastroparesis Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gastroparesis Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Gastroparesis Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastroparesis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastroparesis Drugs, Product Type & Application
2.7 Gastroparesis Drugs Market Competitive Situation and Trends
2.7.1 Gastroparesis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gastroparesis Drugs Players Market Share by Revenue
2.7.3 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastroparesis Drugs Retrospective Market Scenario by Region
3.1 Global Gastroparesis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gastroparesis Drugs Global Gastroparesis Drugs Sales by Region: 2019-2030
3.2.1 Global Gastroparesis Drugs Sales by Region: 2019-2024
3.2.2 Global Gastroparesis Drugs Sales by Region: 2025-2030
3.3 Global Gastroparesis Drugs Global Gastroparesis Drugs Revenue by Region: 2019-2030
3.3.1 Global Gastroparesis Drugs Revenue by Region: 2019-2024
3.3.2 Global Gastroparesis Drugs Revenue by Region: 2025-2030
3.4 North America Gastroparesis Drugs Market Facts & Figures by Country
3.4.1 North America Gastroparesis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gastroparesis Drugs Sales by Country (2019-2030)
3.4.3 North America Gastroparesis Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastroparesis Drugs Market Facts & Figures by Country
3.5.1 Europe Gastroparesis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gastroparesis Drugs Sales by Country (2019-2030)
3.5.3 Europe Gastroparesis Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastroparesis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Gastroparesis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gastroparesis Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Gastroparesis Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gastroparesis Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastroparesis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gastroparesis Drugs Sales by Country (2019-2030)
3.7.3 Latin America Gastroparesis Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastroparesis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastroparesis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gastroparesis Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gastroparesis Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastroparesis Drugs Sales by Type (2019-2030)
4.1.1 Global Gastroparesis Drugs Sales by Type (2019-2024)
4.1.2 Global Gastroparesis Drugs Sales by Type (2025-2030)
4.1.3 Global Gastroparesis Drugs Sales Market Share by Type (2019-2030)
4.2 Global Gastroparesis Drugs Revenue by Type (2019-2030)
4.2.1 Global Gastroparesis Drugs Revenue by Type (2019-2024)
4.2.2 Global Gastroparesis Drugs Revenue by Type (2025-2030)
4.2.3 Global Gastroparesis Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Gastroparesis Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gastroparesis Drugs Sales by Application (2019-2030)
5.1.1 Global Gastroparesis Drugs Sales by Application (2019-2024)
5.1.2 Global Gastroparesis Drugs Sales by Application (2025-2030)
5.1.3 Global Gastroparesis Drugs Sales Market Share by Application (2019-2030)
5.2 Global Gastroparesis Drugs Revenue by Application (2019-2030)
5.2.1 Global Gastroparesis Drugs Revenue by Application (2019-2024)
5.2.2 Global Gastroparesis Drugs Revenue by Application (2025-2030)
5.2.3 Global Gastroparesis Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Gastroparesis Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sumitomo
6.1.1 Sumitomo Corporation Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sumitomo Gastroparesis Drugs Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Cadila Pharmaceuticals
6.2.1 Cadila Pharmaceuticals Corporation Information
6.2.2 Cadila Pharmaceuticals Description and Business Overview
6.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.2.5 Cadila Pharmaceuticals Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Gastroparesis Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Gastroparesis Drugs Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Gastroparesis Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Gastroparesis Drugs Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Kyowa Kirin Pharmaceuticals
6.6.1 Kyowa Kirin Pharmaceuticals Corporation Information
6.6.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
6.6.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.7.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.8 Hanmi Pharm
6.8.1 Hanmi Pharm Corporation Information
6.8.2 Hanmi Pharm Description and Business Overview
6.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hanmi Pharm Gastroparesis Drugs Product Portfolio
6.8.5 Hanmi Pharm Recent Developments/Updates
6.9 Ani Pharmaceuticals
6.9.1 Ani Pharmaceuticals Corporation Information
6.9.2 Ani Pharmaceuticals Description and Business Overview
6.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ani Pharmaceuticals Gastroparesis Drugs Product Portfolio
6.9.5 Ani Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastroparesis Drugs Industry Chain Analysis
7.2 Gastroparesis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastroparesis Drugs Production Mode & Process
7.4 Gastroparesis Drugs Sales and Marketing
7.4.1 Gastroparesis Drugs Sales Channels
7.4.2 Gastroparesis Drugs Distributors
7.5 Gastroparesis Drugs Customers
8 Gastroparesis Drugs Market Dynamics
8.1 Gastroparesis Drugs Industry Trends
8.2 Gastroparesis Drugs Market Drivers
8.3 Gastroparesis Drugs Market Challenges
8.4 Gastroparesis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Gastroparesis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Gastroparesis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Gastroparesis Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Gastroparesis Drugs Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Gastroparesis Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Gastroparesis Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Gastroparesis Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Gastroparesis Drugs Average Price (US$/mg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Gastroparesis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gastroparesis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gastroparesis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Gastroparesis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Gastroparesis Drugs Sales by Region (2019-2024) & (Kg)
Table 18. Global Gastroparesis Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Gastroparesis Drugs Sales by Region (2025-2030) & (Kg)
Table 20. Global Gastroparesis Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Gastroparesis Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Gastroparesis Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Gastroparesis Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Gastroparesis Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Gastroparesis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 27. North America Gastroparesis Drugs Sales by Country (2025-2030) & (Kg)
Table 28. North America Gastroparesis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Gastroparesis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Gastroparesis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 32. Europe Gastroparesis Drugs Sales by Country (2025-2030) & (Kg)
Table 33. Europe Gastroparesis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Gastroparesis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Gastroparesis Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Gastroparesis Drugs Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Gastroparesis Drugs Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Gastroparesis Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Gastroparesis Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gastroparesis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Gastroparesis Drugs Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Gastroparesis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gastroparesis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gastroparesis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Gastroparesis Drugs Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Gastroparesis Drugs Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Gastroparesis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Gastroparesis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Gastroparesis Drugs Sales (Kg) by Type (2019-2024)
Table 51. Global Gastroparesis Drugs Sales (Kg) by Type (2025-2030)
Table 52. Global Gastroparesis Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Gastroparesis Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Gastroparesis Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Gastroparesis Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Gastroparesis Drugs Price (US$/mg) by Type (2019-2024)
Table 59. Global Gastroparesis Drugs Price (US$/mg) by Type (2025-2030)
Table 60. Global Gastroparesis Drugs Sales (Kg) by Application (2019-2024)
Table 61. Global Gastroparesis Drugs Sales (Kg) by Application (2025-2030)
Table 62. Global Gastroparesis Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Gastroparesis Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Gastroparesis Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Gastroparesis Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Gastroparesis Drugs Price (US$/mg) by Application (2019-2024)
Table 69. Global Gastroparesis Drugs Price (US$/mg) by Application (2025-2030)
Table 70. Sumitomo Corporation Information
Table 71. Sumitomo Description and Business Overview
Table 72. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 73. Sumitomo Gastroparesis Drugs Product
Table 74. Sumitomo Recent Developments/Updates
Table 75. Cadila Pharmaceuticals Corporation Information
Table 76. Cadila Pharmaceuticals Description and Business Overview
Table 77. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 78. Cadila Pharmaceuticals Gastroparesis Drugs Product
Table 79. Cadila Pharmaceuticals Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 83. Sanofi Gastroparesis Drugs Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 88. Teva Gastroparesis Drugs Product
Table 89. Teva Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 93. Johnson & Johnson Gastroparesis Drugs Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 98. Pfizer Gastroparesis Drugs Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Kyowa Kirin Pharmaceuticals Corporation Information
Table 101. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 102. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 103. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product
Table 104. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 105. Hanmi Pharm Corporation Information
Table 106. Hanmi Pharm Description and Business Overview
Table 107. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 108. Hanmi Pharm Gastroparesis Drugs Product
Table 109. Hanmi Pharm Recent Developments/Updates
Table 110. Ani Pharmaceuticals Corporation Information
Table 111. Ani Pharmaceuticals Description and Business Overview
Table 112. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 113. Ani Pharmaceuticals Gastroparesis Drugs Product
Table 114. Ani Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gastroparesis Drugs Distributors List
Table 118. Gastroparesis Drugs Customers List
Table 119. Gastroparesis Drugs Market Trends
Table 120. Gastroparesis Drugs Market Drivers
Table 121. Gastroparesis Drugs Market Challenges
Table 122. Gastroparesis Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gastroparesis Drugs
Figure 2. Global Gastroparesis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gastroparesis Drugs Market Share by Type in 2023 & 2030
Figure 4. Prokinetic Agents Product Picture
Figure 5. Antiemetic Agents Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastroparesis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Gastroparesis Drugs Market Share by Application in 2023 & 2030
Figure 9. Diabetic Gastroparesis
Figure 10. Idiopathic Gastroparesis
Figure 11. Global Gastroparesis Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Gastroparesis Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Gastroparesis Drugs Sales (2019-2030) & (Kg)
Figure 14. Global Gastroparesis Drugs Average Price (US$/mg) & (2019-2030)
Figure 15. Gastroparesis Drugs Report Years Considered
Figure 16. Gastroparesis Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Gastroparesis Drugs Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Gastroparesis Drugs Players: Market Share by Revenue in 2023
Figure 19. Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Gastroparesis Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Gastroparesis Drugs Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Gastroparesis Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Gastroparesis Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Gastroparesis Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Gastroparesis Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Gastroparesis Drugs Sales Market Share by Country (2019-2030)
Figure 44. Latin America Gastroparesis Drugs Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Gastroparesis Drugs Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Gastroparesis Drugs Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Gastroparesis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Gastroparesis Drugs by Type (2019-2030)
Figure 54. Global Revenue Market Share of Gastroparesis Drugs by Type (2019-2030)
Figure 55. Global Gastroparesis Drugs Price (US$/mg) by Type (2019-2030)
Figure 56. Global Sales Market Share of Gastroparesis Drugs by Application (2019-2030)
Figure 57. Global Revenue Market Share of Gastroparesis Drugs by Application (2019-2030)
Figure 58. Global Gastroparesis Drugs Price (US$/mg) by Application (2019-2030)
Figure 59. Gastroparesis Drugs Value Chain
Figure 60. Gastroparesis Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
